Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:NBSE

NeuBase Therapeutics (NBSE) Stock Price, News & Analysis

NeuBase Therapeutics logo

About NeuBase Therapeutics Stock (NASDAQ:NBSE)

Advanced Chart

Key Stats

Today's Range
$0.38
$0.38
50-Day Range
$0.38
$0.38
52-Week Range
$0.36
$4.80
Volume
N/A
Average Volume
N/A
Market Capitalization
$1.43 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive NBSE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for NeuBase Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

NBSE Stock News Headlines

Greenlight Capital Q3 2024 Letter
Everyone’s watching Nvidia right now. Here’s why I’m excited.
So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal with Saudi Arabia to power its new AI empire 🤯 We’re talking about hundreds of thousands of chips, including their latest Grace Blackwell supercomputer.
See More Headlines

NBSE Stock Analysis - Frequently Asked Questions

NeuBase Therapeutics, Inc. (NASDAQ:NBSE) announced its earnings results on Thursday, December, 23rd. The company reported ($4.20) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($4.60) by $0.40.

Shares of NeuBase Therapeutics reverse split on Thursday, June 15th 2023.The 1-20 reverse split was announced on Thursday, June 15th 2023. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, June 15th 2023. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split.

Based on aggregate information from My MarketBeat watchlists, some other companies that NeuBase Therapeutics investors own include Pfizer (PFE), Energy Transfer (ET), Sio Gene Therapies (SIOX), Avino Silver & Gold Mines (ASM), Actinium Pharmaceuticals (ATNM), Cytokinetics (cytk) and Enbridge (enb).

Company Calendar

Last Earnings
12/23/2021
Today
7/13/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:NBSE
CIK
1173281
Fax
N/A
Employees
40
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
3,750,000
Free Float
3,456,000
Market Cap
$1.43 million
Optionable
Not Optionable
Beta
N/A
The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

This page (NASDAQ:NBSE) was last updated on 7/13/2025 by MarketBeat.com Staff
From Our Partners